Morning Overview on MSN
Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial
The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked startup, Life Biosciences, has secured clearance from the U.S. Food and Drug ...
Motley Fool Money reports that the median US household savings account balance is $8,000, with disparities across ...
SK Bioscience has officially opened its new global research and process development center in Songdo, Incheon, where Korea’s biopharmaceutical sector has a subs ...
SK Bioscience on Monday completed its relocation to its new headquarters in Incheon, as the company seeks to transform its ...
If you click on links we provide, we may receive compensation. Elm Biosciences — the brand Stewart created with dermatologist Dr. Dhaval Bhanusali — also released a campaign fronted by Helena ...
Cogent Biosciences, Inc. (NASDAQ:COGT) is among the 20 Best Performing Stocks in 2025. Based on a research note dated January 6, 2026, The Fly reported that H.C. Wainwright reaffirmed a Buy rating and ...
BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...
-- Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, ...
Vyne Therapeutics is set to combine with Yarrow Bioscience in an all-stock merger. Vyne, a clinical-stage biopharmaceutical company, and Yarrow Bioscience, a clinical-stage biotechnology company said ...
Colossal Biosciences is pulling one final surprise out of its hat in 2025. Announced today, the company’s nonprofit arm—The Colossal Foundation—secured an additional $50 million in funding, doubling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results